Skip to content

Nurix Therapeutics

US · NRIX #2679 by market cap Listed 2020
22.73 +0.13 +0.58%
Live - 5344 symbols - heartbeat 64s ago · 2026-10-08 07:00
Pre-market 22.73 0.00%
After-hours 22.73 0.00%
Market cap
2.36B
P/B
5.86
EPS
-3.05
Reader sentiment Are you bullish or bearish on NRIX?

Anonymous reader poll. Unscientific, not investment advice.

Recent news

  • Rating change
    H.C. Wainwright Maintains Nurix Therapeutics(NRIX.US) With Buy Rating, Maintains Target Price $32
    Market Newswire · 2026/6/11
  • RBC Capital Maintains Nurix Therapeutics(NRIX.US) With Buy Rating, Raises Target Price to $36
    Market Newswire · 2026/8/10
  • Rating change
    Wells Fargo Maintains Nurix Therapeutics(NRIX.US) With Hold Rating, Maintains Target Price $25
    Market Newswire · 2026/7/14
  • Rating change
    Oppenheimer Initiates Nurix Therapeutics(NRIX.US) With Buy Rating, Announces Target Price $28
    Market Newswire · 2026/6/29
  • Rating change
    J.P. Morgan Maintains Nurix Therapeutics(NRIX.US) With Buy Rating
    Market Newswire · 2026/6/12
  • Rating change
    Morgan Stanley Maintains Nurix Therapeutics(NRIX.US) With Buy Rating, Raises Target Price to $38
    Market Newswire · 2026/7/28
  • Rating change
    Needham Maintains Nurix Therapeutics(NRIX.US) With Buy Rating, Maintains Target Price $26
    Market Newswire · 2026/5/16
  • Rating change
    Stifel Maintains Nurix Therapeutics(NRIX.US) With Buy Rating, Maintains Target Price $34
    Market Newswire · 2026/6/15
  • Morgan Stanley Maintains Nurix Therapeutics(NRIX.US) With Buy Rating, Maintains Target Price $38
    Market Newswire · 2026/7/28
  • Rating change
    Piper Sandler Maintains Nurix Therapeutics(NRIX.US) With Buy Rating, Maintains Target Price $35
    Market Newswire · 2026/5/13
  • Rating change
    Analysts Offer Insights on Healthcare Companies: Coya Therapeutics, Inc. (COYA), Nurix Therapeutics (NRIX) and Immunic (IMUX)
    TipRanks · 2026/6/9
  • Rating change
    Mizuho Securities Maintains Nurix Therapeutics(NRIX.US) With Buy Rating, Raises Target Price to $34
    Market Newswire · 2026/7/13
  • UBS Maintains Nurix Therapeutics(NRIX.US) With Buy Rating, Raises Target Price to $31
    Market Newswire · 2026/7/22
  • Rating change
    Jefferies Maintains Nurix Therapeutics(NRIX.US) With Buy Rating, Maintains Target Price $45
    Market Newswire · 2026/7/8
  • Rating change
    Truist Financial Maintains Nurix Therapeutics(NRIX.US) With Buy Rating
    Market Newswire · 2026/5/15
  • Needham Maintains Nurix Therapeutics(NRIX.US) With Buy Rating, Maintains Target Price $34
    Market Newswire · 2026/8/4
  • Rating change
    BTIG Maintains Nurix Therapeutics(NRIX.US) With Buy Rating, Maintains Target Price $32
    Market Newswire · 2026/7/1
  • Rating change
    A Quick Look at Today's Ratings for Nurix Therapeutics(NRIX.US), With a Forecast Between $25 to $45
    Market Newswire · 2026/6/9
  • A Quick Look at Today's Ratings for Nurix Therapeutics(NRIX.US), With a Forecast Between $28 to $40
    Market Newswire · 2026/7/11
  • Rating change
    A Quick Look at Today's Ratings for Nurix Therapeutics(NRIX.US), With a Forecast Between $25 to $32
    Market Newswire · 2026/6/10

Headlines are aggregated automatically and are not independently verified or edited by our team.

Quote time 2026-10-08 07:00:07 · For reference only, not investment advice and not tailored to your situation.